These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24968725)

  • 1. Radiation recall after a transarterial hepatic chemoembolization.
    Wunderle KA; Sands MJ
    J Vasc Interv Radiol; 2014 Jul; 25(7):1027-8. PubMed ID: 24968725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.
    Saif MW; Kaley K; Brennan M; Garcon MC; Rodriguez G; Rodriguez T
    JOP; 2013 Sep; 14(5):498-501. PubMed ID: 24018594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
    Fine RL; Gulati AP; Krantz BA; Moss RA; Schreibman S; Tsushima DA; Mowatt KB; Dinnen RD; Mao Y; Stevens PD; Schrope B; Allendorf J; Lee JA; Sherman WH; Chabot JA
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):663-70. PubMed ID: 23370660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemoembolization of liver metastasis].
    Nørgaard H
    Ugeskr Laeger; 2012 Mar; 174(12):784. PubMed ID: 22433541
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
    Saif MW; Black G; Johnson M; Russo S; Diasio R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
    Rivera E; Meyers C; Groves M; Valero V; Francis D; Arun B; Broglio K; Yin G; Hortobagyi GN; Buchholz T
    Cancer; 2006 Sep; 107(6):1348-54. PubMed ID: 16909414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
    Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
    Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
    Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.
    Diaco DS; Hajarizadeh H; Mueller CR; Fletcher WS; Pommier RF; Woltering EA
    Am J Surg; 1995 May; 169(5):523-8. PubMed ID: 7747834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
    Gao YH; An X; Sun WJ; Cai J; Cai MY; Kong LH; Lin JZ; Liu GC; Tang JH; Wu XJ; Chen G; Pan ZZ; Ding PR
    J Surg Oncol; 2014 Apr; 109(5):478-82. PubMed ID: 24288203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine.
    Ortmann E; Hohenberg G
    J Clin Oncol; 2002 Jul; 20(13):3029-30. PubMed ID: 12089233
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors.
    Claringbold PG; Price RA; Turner JH
    Cancer Biother Radiopharm; 2012 Nov; 27(9):561-9. PubMed ID: 23078020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of capecitabine and temozolomide combination in well-differentiated neuroendocrine tumors: Jordan experience.
    Abbasi S; Kashashna A; Albaba H
    Pancreas; 2014 Nov; 43(8):1303-5. PubMed ID: 25036906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of liver metastases of rectal carcinoid successfully treated with hepatic arterial infusion of methotrexate and 5-fluorouracil].
    Takeuchi I; Ishida H; Suzuki T; Nakada H; Tada M; Idezuki Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1929-32. PubMed ID: 10560428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series.
    Saranga-Perry V; Morse B; Centeno B; Kvols L; Strosberg J
    Neuroendocrinology; 2013; 97(4):318-21. PubMed ID: 23296364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of multiple liver metastases from rectal carcinoid tumor successfully treated with arterial infusion chemotherapy using degradable starch microspheres (DSM)].
    Doi T; Homma H; Mezawa S; Kukitsu T; Miyanishi K; Takada K; Niitsu Y
    Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):410-5. PubMed ID: 11400271
    [No Abstract]   [Full Text] [Related]  

  • 17. Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
    Tipples K; Kolluri RB; Raouf S
    J Oncol Pharm Pract; 2009 Dec; 15(4):237-9. PubMed ID: 19276137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
    Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
    Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
    Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
    J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.
    Welin S; Sorbye H; Sebjornsen S; Knappskog S; Busch C; Oberg K
    Cancer; 2011 Oct; 117(20):4617-22. PubMed ID: 21456005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.